These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21880459)

  • 1. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery.
    Soga Y; Iida O; Hirano K; Suzuki K; Tosaka A; Yokoi H; Nobuyoshi M
    J Vasc Surg; 2011 Oct; 54(4):1058-66. PubMed ID: 21880459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol.
    Soga Y; Iida O; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):541-8. PubMed ID: 21805619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses.
    Iida O; Uematsu M; Soga Y; Hirano K; Suzuki K; Yokoi H; Muramatsu T; Inoue N; Nanto S; Nagata S
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):611-7. PubMed ID: 21805562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population.
    Gillgren P; Pettersson H; Fernström J; Falkenberg M; Delle M; Konrad P; Lindström D
    Ann Vasc Surg; 2011 Aug; 25(6):758-65. PubMed ID: 21439769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.
    Hu H; Zhang H; He Y; Jin W; Tian L; Chen X; Li M
    Ann Vasc Surg; 2011 Feb; 25(2):210-6. PubMed ID: 21315233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study.
    Trabattoni D; Agrifoglio M; Cappai A; Bartorelli AL
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):678-82. PubMed ID: 20216226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
    Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
    J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.
    Sakamoto Y; Hirano K; Iida O; Soga Y; Suzuki K; Muramatsu T; Tsukahara R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E251-6. PubMed ID: 23536429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenting of femoropopliteal lesions using interwoven nitinol stents.
    Brescia AA; Wickers BM; Correa JC; Smeds MR; Jacobs DL
    J Vasc Surg; 2015 Jun; 61(6):1472-8. PubMed ID: 25752693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.